FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092240 [Registered on: 04/08/2025] Trial Registered Prospectively
Last Modified On: 26/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Study to see if a pain relief medicine can also improve sleep after surgery for leg fractures. 
Scientific Title of Study   Effect of Gabapentin on sleep quality and post operative pain relief in patients undergoing lower limb trauma surgery 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vanita Ahuja 
Designation  Professor  
Affiliation  Government Medical College and Hospital Chandigarh , Sector 32-B 
Address  Department of Anaesthesia and Intensive Care,Government Medical College and Hospital Chandigarh , Sector 32-B

Chandigarh
CHANDIGARH
160030
India 
Phone  9646121649  
Fax    
Email  vanitaahujameetings2020@gmail.con  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vanita Ahuja 
Designation  Professor  
Affiliation  Government Medical College and Hospital Chandigarh , Sector 32-B 
Address  Department of Anaesthesia and Intensive Care,Government Medical College and Hospital Chandigarh , Sector 32-B

Chandigarh
CHANDIGARH
160030
India 
Phone  9646121649  
Fax    
Email  vanitaahujameetings2020@gmail.con  
 
Details of Contact Person
Public Query
 
Name  Riya Ahuja 
Designation  Postgraduate junior resident 
Affiliation  Government Medical College and Hospital Chandigarh , Sector 32-B 
Address  Department of Anaesthesia and Intensive Care,Government Medical College and Hospital Chandigarh , Sector 32-B

Chandigarh
CHANDIGARH
160030
India 
Phone  9465468932  
Fax    
Email  riya20ahuja20@gmail.com  
 
Source of Monetary or Material Support  
Government Medical College and Hospital Chandigarh, Sect 32-B 
 
Primary Sponsor  
Name  Department of Anaesthesia and Intensive Care 
Address  Department of Anaesthesia and Intensive Care, Government Medical College and Hospital Chandigarh , Sect 32-B 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vanita Ahuja  Government Medical College and Hospital ,Chandigarh   Department of Anaesthesia and Intensive Care, Level-5, Government Medical College and Hospital ,Chandigarh , Sector 32-B
Chandigarh
CHANDIGARH 
9646121649

vanitaahujameetings2020@mail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Instituitional Ethics Committee, Government Medical College and Hospital Chandigarh   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M249||Joint derangement, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Gabapentin  Patients will be given 300mg Gabapentin 2 hours before surgery and 300mg at 12 hours after surgery 
Comparator Agent  Placebo   Patients will be given placebo drug 2 hours before surgery and 12 hours after surgery  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Age 18-65 years
2.American Society of Anaesthesiologists (ASA) physical status I and II
3.Lower limb surgery following trauma less than three months
4.Duration of surgery less than equal to 4 hours 
 
ExclusionCriteria 
Details  1. Patients having head injury and/or polytrauma
2. Contraindications to spinal anaesthesia
3. Contraindications to Gabapentin
4. Pregnant and lactating women
5. Patients not able to understand VAS or PSQI scale
6. Patients having history of substance abuse
7. Patients with preexisting sleep disorders
8. Patients already on Gabapentin 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Sleep quality using PSQI sleep score
 
48 hours after surgery in ward 
 
Secondary Outcome  
Outcome  TimePoints 
1. Sleep quality using PSQI sleep score
2.Postoperative pain relief using VAS score
3. Haemodynamics
4. Ramsay sedation score
5. Total cumulative rescue analgesia (Diclofenac) consumed
6. Total cumulative rescue analgesia(tramadol) consumed 
1.Preoperative ,24 hours after surgery
2.Preop, PACU, 4,8,12,24 and 48 hours
3. Preop, PACU, 4,8,12,24 and 48 h
4. Preop,PACU, 4,8,12,24 and 48 h
5. Preop, PACU, 4,8,12,24 and 48 h
6. Preop PACU, 4,8,12,24 and 48 h 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   20/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study will evaluate the effect of Gabapentin on sleep quality and postoperative pain relief in patients undergoing lower limb trauma surgery.Patients experience poor sleep and significant pain after lower limb trauma surgery.Gabapentin has already been used for treatment of neuropathic pain with the benefit of reduction in opioid requirements and improving function outcomes and sleep.We hypothesise that there is a difference in the response in terms of sleep scores and postoperative pain relief with the use of Gabapentin compared to a placebo drug.
 
Close